Share this page!

Navroop Singh Profile picture
Twitter logo
12 May, 7 tweets, 2 min read
Use of SARS-CoV as Biological Weapon !
In 2003, A Famous Microbiologist concluded that SARS Virus is neither a Recombinant or a mutant strain and it can not be excluded that it is of Unnatural Evolution i.e has no direct ancestor or surviving host in nature. 🤷🏻‍♂️
For the first time PLA’s BOOK written by its scientists in 2015 elucidates that SARS-CoV is of Unnatural Origin.
PLA Scientists argue that SARS CoV does not come from Horsehoe bats as is widely believed say we have intimated scientific general. They say we have observed that SARS Virus have reverse evolved as in decrease pathogencity & virulence with time as was seen in SARS (2002) & MERS.
Then what changed between 2002 & 2020 is that Shi Zhengli and her team discovered Bat Coronavirus considered to be very virulent took its spike Protien and merge it with SARS CoV and u had the prefect virus ready to infect humans. There is no Bat Origin to it.
Study Where Shi Zhengli talks about it.
PLA Scientists - SARS CoV has not followed Natural Evolution theory i.e. jumping inter species from any animal source to Humans. SARS entered humans in an unnatural way. [2015 - Book] !

• • •

Missing some Tweet in this thread? You can try to force a refresh
　

Keep Current with Navroop Singh

Navroop Singh Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @NavroopSingh_

Navroop Singh Profile picture
10 May
So Despite state purchasing Vaccines which states get how many is decided by Central Government on Pro-Rata population basis as per the affidavit filed in SC. Delhi was allocated 5.7 Lakhs dosages for month of may against a total of 1.34 crore total dosages ordered.
That stock gets over in 1 day for COVAXIN & 4 days for COVIDSHIELD. Now Delhi has to wait the may end/june for next tranche unless center releases some of its stock or manages to release more towards Delhi.
The logic Center has put justifying this procurement procedure before SC is to maintain balance & parity between states and their bargaining power, quota of each state per month to be decided by Center despite direct procurement.
Read 7 tweets
Navroop Singh Profile picture
10 May
Cambridge University medical team Analysis of samples from the patient showed that the virus evolved rapidly after the plasma therapy, developing mutations that changed how it could infect cells and resist antibodies. nature.com/articles/s4158…
Last summer, as the second wave of COVID-19 cases was sweeping the United Kingdom, a man in his 70s was admitted to his local hospital where he tested positive for SARS-CoV-2.
He was sent home, but a month later he checked into the hospital at Cambridge University, unable to shake the virus.
Read 16 tweets
Navroop Singh Profile picture
8 May
Rahu&Ketu in Vrishab(Rohini)/Vrischik(Anuradha), Shani in Shravana & Shukra in Mithun from 29th May to 22nd June 2021. Mangal comes in Kark-Makar Axis directly aspecting Shani from 02nd June to 20th July. Some very turbulent times for our country.
Shani gets Vakri on 23rd May and the Guru vakri on June 20th. Guru enters Makar Rashi on 14 Sept & leaves on 21st November its last touch with Shani after the Grand Conjunction. Shani & Guru Yuti though in Different Nakshatra could sprout a third wave in Autumn (Fall).
KN Rao on Mundane Astrology has talked abt Rahu & Ketu in Vrishab/Vrishchik Axis and Kark/Makar Axis when these two axis are afflicted India has suffered setbacks. Also Venus in Gemini is again troublesome period. Some very heavy energy from June 2nd to June 23rd .
Read 5 tweets
Navroop Singh Profile picture
7 May
Kejriwal is earning a lot of Goodwill by his Vaccination drive whitewashing his failures in health care. Cultivating a whole new generation between 18-30 for smooth vaccination drive despite the trials for slots on COWIN.
The guy has got Devil’s luck from Beds to Oxygen to Tankers everything he blames the center who does the bulk of lifting to bring Delhi out but takes the credit for Vaccination Drive in Delhi. Plus he buys positive press with Ads & now vaccines for journalists.
As soon as his HC rapped him for total system failure, Vaccine Drive begins. Moment his MLAs gets caught in Black Marketing of Oxygen he announces Free Vaccines for Journalists. How to buy good press & sense of timing is something that Kejriwal does well.
Read 5 tweets
Navroop Singh Profile picture
7 May
Dear @narendramodi sir, the Country is looking towards you to guide us out of this ferocious 2nd wave of the Pandemic. Specially the Middle Class which has been your most loyal and influential supporters have been really battered by the Pandemic’s 2nd wave.
There is hardly any family which has not been affected or touched by the wrath of the second wave. Every house a story losing a loved one. People have spent through their savings to protect their loved one from this Virus in the second wave.
They are emotionally battered & financially blown in this wave. Middle Class in Cities/Towns need empathy & healing touch and the outreach must come from @PMOIndia itself. I hope he addresses this class acknowledges their pain, and tells them that Government is doing all it can.
Read 7 tweets
Navroop Singh Profile picture
6 May
Ocugen announces studies showing COVAXIN potentially effective against three key variants of SARS-CoV-2   globenewswire.com/news-release/2…
Covaxin works well against UK variant, B.1.1.7, as well as the Indian double mutant variant, B.1.617. It is notable that the Brazilian variant, B1.128.2, contains the E484K mutation that was found in New York.
Ocugen is developing COVAXIN, Bharat Biotech’s COVID-19 vaccine candidate, for the U.S. market. In the recently shared second interim results of the Phase 3 clinical trial, COVAXIN demonstrated 78% overall efficacy and 100% in severe COVID-19 disease (including hospitalization).
Read 4 tweets

Did Thread Reader help you today?

Support us! We are indie developers!

This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!

Like this author's thread?

Get emails when @NavroopSingh_ has new unrolls!

Check out other threads from @NavroopSingh_!

Read all threads by @NavroopSingh_

:(